跳至主要内容
临床试验/NL-OMON23578
NL-OMON23578招募中不适用

I-131 remnant ablation in differentiated thyroid cancer - Optimal treatment with maximal outcome.

Prof.dr. T.P. Links, endocrinologist0 个研究点目标入组 144 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
144

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Low and high risk patients (according American Joint Committee on Cancer, AJCC 6) with recently diagnosed histological proven DTC, who have to be treated with ablation therapy. TNM stages T1>1cm, T2, T3, N0, N1, M0 are to be included;
  • 2. Aged 18 years or older;

排除标准

  • 1. Stage T4;
  • 2. Stage M1 when known before ablation;

研究者

发起方
Prof.dr. T.P. Links, endocrinologist

相似试验